Skip to main content
. 2019 Feb 1;10(10):1070–1084. doi: 10.18632/oncotarget.26626

B) Classified according to antibodies (n = 55).

Anti-EGFR (n = 17) Anti-VEGF (n = 38)
Any grade, n (%) Grade 3/4,
n (%)
Any grade, n (%) Grade 3/4, n (%) P value
Leukopenia 14 (82) 1 (6) 30 (79) 2 (5) 1.00
Neutropenia 15 (88) 9 (53) 29 (76) 19 (50) 0.830
Anemia 6 (35) 0 24 (63) 0 0.318
Thrombocytopenia 6 (35) 0 8 (21) 0 0.527
Hypomagnesemia 10 (59) 2 (12) 6 (16) 0 0.039
Alopecia 4 (24) 0 2 (6) 0 0.169
Fatigue 6 (35) 0 16 (43) 0 1.00
FN 0 0 0 0
Diarrhea 13 (77) 2 (12) 18 (49) 1 (3) 0.350
Anorexia 8 (47) 0 9 (24) 0 0.253
Nausea 12 (70) 1 (6) 17 (46) 0 0.347
Neurotoxicity 13 (77) 0 30 (81) 1 (3) 1.00
Hypertension 2 (12) 0 21 (57) 0 0.045
Proteinuria 5 (29) 0 22 (60) 1 (3) 0.295
Rash acneiform 15 (88) 0 3 (8) 0 <0.001